These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37984601)

  • 1. Bisphenol A analogues and metabolic syndrome in women with polycystic ovary syndrome.
    Majewska J; Berg A; Jurewicz J; Owczarek K; Zajdel R; Kilanowicz A; Wasik A; Rachoń D
    Reprod Toxicol; 2024 Jan; 123():108511. PubMed ID: 37984601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome - is there an association?
    Jurewicz J; Majewska J; Berg A; Owczarek K; Zajdel R; Kaleta D; Wasik A; Rachoń D
    Environ Pollut; 2021 Mar; 272():115962. PubMed ID: 33223334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to Bisphenol A Analogs and the Thyroid Function and Volume in Women of Reproductive Age-Cross-Sectional Study.
    Milczarek-Banach J; Rachoń D; Bednarczuk T; Myśliwiec-Czajka K; Wasik A; Miśkiewicz P
    Front Endocrinol (Lausanne); 2020; 11():587252. PubMed ID: 33542704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphenol A Diglycidyl Ether (BADGE) and Bisphenol Analogs, but Not Bisphenol A (BPA), Activate the CatSper Ca
    Rehfeld A; Andersson AM; Skakkebæk NE
    Front Endocrinol (Lausanne); 2020; 11():324. PubMed ID: 32508751
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome.
    Konieczna A; Rachoń D; Owczarek K; Kubica P; Kowalewska A; Kudłak B; Wasik A; Namieśnik J
    Reprod Toxicol; 2018 Dec; 82():32-37. PubMed ID: 30266220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to bisphenol A and its analogs and polycystic ovarian syndrome in women of childbearing age: A multicenter case-control study.
    Zhan W; Tang W; Shen X; Xu H; Zhang J
    Chemosphere; 2023 Feb; 313():137463. PubMed ID: 36470355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.
    Kandaraki E; Chatzigeorgiou A; Livadas S; Palioura E; Economou F; Koutsilieris M; Palimeri S; Panidis D; Diamanti-Kandarakis E
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E480-4. PubMed ID: 21193545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the materno-fetal transfer of fifteen structurally related bisphenol analogues using an ex vivo human placental perfusion model.
    Gély CA; Lacroix MZ; Morin M; Vayssière C; Gayrard V; Picard-Hagen N
    Chemosphere; 2021 Aug; 276():130213. PubMed ID: 34088095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome.
    Fu C; Minjie C; Weichun Z; Huihuang Y; Guishan C; Qingxia H; Xiaoping Y; Lan C; Ping W; Chujia L; Guoshu Y
    Hormones (Athens); 2020 Sep; 19(3):439-445. PubMed ID: 32562143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome.
    Vahedi M; Saeedi A; Poorbaghi SL; Sepehrimanesh M; Fattahi M
    Environ Sci Pollut Res Int; 2016 Dec; 23(23):23546-23550. PubMed ID: 27614642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome?
    Milanović M; Milošević N; Sudji J; Stojanoski S; Atanacković Krstonošić M; Bjelica A; Milić N; Medić Stojanoska M
    Clin Chim Acta; 2020 Aug; 507():257-263. PubMed ID: 32387634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary bisphenol A in women with polycystic ovary syndrome - a possible suppressive effect on steroidogenesis?
    Lazúrová Z; Figurová J; Hubková B; Mašlanková J; Lazúrová I
    Horm Mol Biol Clin Investig; 2021 Jun; 42(3):303-309. PubMed ID: 34118794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome.
    Akgül S; Sur Ü; Düzçeker Y; Balcı A; Kızılkan MP; Kanbur N; Bozdağ G; Erkekoğlu P; Gümüş E; Kocer-Gumusel B; Derman O
    Gynecol Endocrinol; 2019 Dec; 35(12):1084-1087. PubMed ID: 31219355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphenol A and polycystic ovary syndrome in human: A systematic review.
    Urbanetz LAML; Soares-Junior JM; Dos Santos Simões R; Maciel GAR; Baracat MCP; Baracat EC
    Int J Gynaecol Obstet; 2024 Jul; 166(1):190-203. PubMed ID: 38197560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study.
    Vagi SJ; Azziz-Baumgartner E; Sjödin A; Calafat AM; Dumesic D; Gonzalez L; Kato K; Silva MJ; Ye X; Azziz R
    BMC Endocr Disord; 2014 Oct; 14():86. PubMed ID: 25348326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls.
    Akın L; Kendirci M; Narin F; Kurtoglu S; Saraymen R; Kondolot M; Koçak S; Elmali F
    Acta Paediatr; 2015 Apr; 104(4):e171-7. PubMed ID: 25469562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
    Palioura E; Diamanti-Kandarakis E
    Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome.
    Yang H; Chen Y; Liu C
    Gynecol Endocrinol; 2023 Dec; 39(1):2172154. PubMed ID: 36708155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphenol-A and polycystic ovary syndrome: a review of the literature.
    Kechagias KS; Semertzidou A; Athanasiou A; Paraskevaidi M; Kyrgiou M
    Rev Environ Health; 2020 Nov; 35(4):323-331. PubMed ID: 32663175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.